Despite marijuana remaining a Schedule I drug on the federal level, 2024 has been a huge year for marijuana research. As ...

Editorial Note: This content has been independently collected by the Forbes Advisor team and is offered on a non-advised basis. This content is not part of the comparison service provided by ...